[1]XIA C,DONG X,LI H,et al.Cancer statistics in China and United States,2022:profiles,trends,and determinants[J].Chin Med J(Engl),2022,135(5):584-590.
[2]MULLER-HERMELINK HK,STROBEL P,ZETTL A,et al.Pathology and genetics of tumours of the lung,pleura,thymus and heart(WHO classification of tumours series)[M].Lyon:IARC Press,2004:26-67.
[3]MOLINA JR,YANG P,CASSIVI SD,et al.Non-small cell lung cancer:epidemiology,risk factors,treatment,and survivorship[J].Mayo Clin Proc,2008,83(5):584-594.
[4]LEE CC,SHIAO HY,WANG WC,et al.Small-molecule EGFR tyrosine kinase inhibitors for the treatment of cancer[J].Expert Opin Investig Drugs,2014,23(10):1333-1348.
[5]MOORE MJ,GOLDSTEIN D,HAMM J,et al.Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer:a phase III trial of the National Cancer Institute of Canada Clinical Trials Group[J].J Clin Oncol,2007,25(15):1960-1966.
[6]BOULOUGOURIS P,ELDER J.Epidermal growth factor receptor structure,regulation,mitogenic signalling and effects of activation[J].Anticancer Res,2001,21(4A):2769-2775.
[7]CALIFANO R,TARIQ N,COMPTON S,et al.Expert consensus on the management of adverse events from EGFR tyrosine kinase inhibitors in the UK[J].Drugs,2015,75(12):1335-1348.
[8]TROTT O,OLSON AJ.AutoDock Vina:improving the speed and accuracy of docking with a new scoring function,efficient optimization,and multithreading[J].J Comput Chem,2010,31(2):455-461.
[9]徐森楠,庄莉,翟园园,等.基于网络药理学研究二至丸防治骨质疏松症的物质基础与作用机制[J].中国药学杂志,2018,53(22):1913-1920.
XU SN,ZHUANG L,ZHAI YY,et al.Network-based pharmacological study of the material basis and mechanism of action of Erzhi Pills in the prevention and treatment of osteoporosis[J].Chinese Journal of Pharmacy,2018,53(22):1913-1920.
[10]CHO JH,LIM SH,AN HJ,et al.Osimertinib for patients with non-small-cell lung cancer harboring uncommon EGFR mutations:A multicenter,open-label,phase II trial(KCSG-LU15-09)[J].J Clin Oncol,2020,38(5):488-495.
[11]WAHLER G,HECK DE,HEINDEL ND,et al.Antioxidant/stress response in mouse epidermis following exposure to nitrogen mustard[J].Exp Mol Pathol,2020,114:104410.
[12]LICHTENBERGER BM,GERBER PA,HOLCMANN M,et al.Epidermal EGFR controls cutaneous host defense and prevents inflammation[J].Sci Transl Med,2013,5(199):199ra111.
[13]叶丹,谢长生.表皮生长因子受体酪氨酸激酶抑制剂相关皮疹的中西医治疗进展[J].肿瘤学杂志,2019,25(03):256-260.
YE D,XIE CS.Advances in Chinese and Western medicine for the treatment of epidermal growth factor receptor tyrosine kinase inhibitor-associated skin rashes[J].Journal of Oncology,2019,25(03):256-260.
[14]LI Y,FU R,JIANG T,et al.Mechanism of lethal skin toxicities induced by epidermal growth factor receptor inhibitors and related treatment strategies[J].Front Oncol,2022,12:804212.
[15]WILGUS TA,ROSS MS,PARRETT ML,et al.Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation[J].Prostaglandins Other Lipid Mediat,2000,62(4):367-384.
[16]WANG Y,ZHANG Y,DING C,et al.Exploration of the potential mechanism of Qi Yin San Liang San Decoction in the treatment of EGFRI-related adverse skin reactions using network pharmacology and in vitro experiments[J].Front Oncol,2022,12:790713.
[17]FAOUR WH,MANCINI A,HE QW,et al.T-cell-derived interleukin-17 regulates the level and stability of cyclooxygenase-2(COX-2) mRNA through restricted activation of the p38 mitogen-activated protein kinase cascade:role of distal sequences in the 3'-untranslated region of COX-2 mRNA[J].J Biol Chem,2003,278(29):26897-26907.
[18]LINDNER D,ZIETSCH C,BECHER PM,et al.Differential expression of matrix metalloproteases in human fibroblasts with different origins[J].Biochem Res Int,2012,2012:875742.
[19]SHIH MF,CHERNG JY.Potential protective effect of fresh grown unicellular green algae component(resilient factor) against PMA- and UVB-induced MMP1 expression in skin fibroblasts[J].Eur J Dermatol,2008,18(3):303-307.
[20]BREMBILLA NC,MONTANARI E,TRUCHETET ME,et al.Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts:differential effects in healthy and systemic sclerosis fibroblasts[J].Arthritis Res Ther,2013,15(5):R151.
[21]MHHP A,SH B,MA A.Wound healing potential of pomegranate peel extract in human dermal fibroblasts through regulating the expression of FN1 gene[J].South African Journal of Botany,2022,146:222-229.
[22]KNAUP J,VERWANGER T,GRUBER C,et al.Epidermolysis bullosa - a group of skin diseases with different causes but commonalities in gene expression[J].Exp Dermatol,2012,21(7):526-530.
[23]MOON SJ,BAE JM,PARK KS,et al.Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis[J].Ann Rheum Dis,2019,78(6):817-825.
[24]JEON HH,YU Q,LU Y,et al.FOXO1 regulates VEGFA expression and promotes angiogenesis in healing wounds[J].J Pathol,2018,245(3):258-264.
[25]CHEN J,GU Z,WU M,et al.C-reactive protein can upregulate VEGF expression to promote ADSC-induced angiogenesis by activating HIF-1α via CD64/PI3k/Akt and MAPK/ERK signaling pathways[J].Stem Cell Res Ther,2016,7(1):114.
[26]ZHAO M,LUO J,XIAO B,et al.Endoplasmic reticulum stress links psoriasis vulgaris with keratinocyte inflammation[J].Postepy Dermatol Alergol,2020,37(1):34-40.
[27]YANG GH,LI S,PESTKA JJ.Down-regulation of the endoplasmic reticulum chaperone GRP78/BiP by vomitoxin(Deoxynivalenol)[J].Toxicol Appl Pharmacol,2000,162(3):207-217.